Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | AMPD2 | Q01433 | 1/20 | 0.35 |
| ▸ | UBE2M | P61081 | 1/20 | 0.35 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11534640 | 0.89 | GAA (0.41) | BCHETSHRKMT2A | |
| SCHEMBL11531879 | 0.88 | BCHE (0.38) | GRM6BCHETSHR | |
| SCHEMBL11533475 | 0.86 | GRM6 (0.34) | GRM6BCHEKMT2A | |
| SCHEMBL11533481 | 0.86 | GRM6 (0.34) | GRM6BCHEKMT2A | |
| SCHEMBL11534917 | 0.85 | BCHE (0.42) | BCHETSHR | |
| SCHEMBL11530555 | 0.84 | SIGMAR1 (0.35) | — | |
| SCHEMBL11440895 | 0.84 | MAPT (0.36) | GRM6BCHETSHR | |
| SCHEMBL11530434 | 0.84 | KDM4E (0.42) | BCHE | |
| SCHEMBL11447544 | 0.84 | GRM6 (0.33) | GRM6 | |
| SCHEMBL11532967 | 0.83 | GAA (0.38) | TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4141883-A | Stabilization of synthetic polymers by penta-or-hexa-substituted 4-piperidinol derivatives | SANKYO COMPANY, LIMITED (JP) | 1979-02-27 | — | — | US | disclosed |
| US-4075165-A | 2,2,6,6-TETRA-SUBSTITUTED-4-PIPERIDINOL | CIBA-GEIGY CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |